Seneca House Advisors Eli Lilly & CO Transaction History

Seneca House Advisors

$225 Million
Q2 2025

A detailed history of Seneca House Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Seneca House Advisors holds 980 shares of LLY stock, worth $613,137. This represents 0.34% of its overall portfolio holdings.

Number of Shares

980

Previous 1,113 11.95%

Holding current value

$613,137

Previous $919,000 16.97%

% of portfolio

0.34%

Previous 0.4%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	SELL	$713.71 - $898.95 $94,923 - $119,560	-133 Reduced 11.95%	980 $763,000
Q1 2025 Apr 11, 2025	SELL	$725.72 - $929.72 $68,943 - $88,323	-95 Reduced 7.86%	1,113 $919,000
Q4 2024 Jan 17, 2025	BUY	$727.2 - $932.06 $63,266 - $81,089	87 Added 7.76%	1,208 $932,000
Q3 2024 Oct 04, 2024	BUY	$772.14 - $960.02 $772 - $960	1 Added 0.09%	1,121 $993,000
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $37,693 - $47,270	-52 Reduced 4.44%	1,120 $1.01 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $100,674 - $134,687	-170 Reduced 12.67%	1,172 $911,000
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $42,540 - $50,149	-81 Reduced 5.69%	1,342 $782,000
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $22,169 - $30,564	51 Added 3.72%	1,423 $764,000
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $16,484 - $22,042	-47 Reduced 3.31%	1,372 $643,000
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $18,637 - $21,889	60 Added 4.42%	1,419 $487,000
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $4,823 - $5,620	-15 Reduced 1.09%	1,359 $497,000
Q3 2022 Oct 07, 2022	BUY	$296.48 - $337.87 $7,412 - $8,446	25 Added 1.85%	1,374 $444,000
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $167,238 - $196,362	600 Added 80.11%	1,349 $437,000
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $5,867 - $7,291	-25 Reduced 3.23%	749 $215,000
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $44,970 - $55,808	-200 Reduced 20.53%	774 $214,000
Q3 2021 Oct 14, 2021	SELL	$221.6 - $272.71 $5,540 - $6,817	-25 Reduced 2.5%	974 $225,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $27,082 - $35,031	-150 Reduced 13.05%	999 $229,000
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $188,803 - $244,415	1,149 New	1,149 $215,000

Others Institutions Holding LLY

# of Institutions

4,400

Shares Held

756M

Call Options Held

9.9M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $594B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seneca House Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Seneca House Advisors with notifications on news.

Account

Seneca House Advisors Eli Lilly & CO Transaction History